Europe Molecular Diagnostics Market By Product & Services (Reagents & Kits, Instruments, Software & Services), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, Hybridization, DNA Sequencing & Next-Generation Sequencing, Microarray), Application (Infectious Diseases, Oncology, Blood Screening, Genetic Tests, Microbiology), End User (Hospital & Academic Laboratories, Reference Laboratories)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Molecular Diagnostics Market, by Product & Services
1.4.2 Europe Molecular Diagnostics Market, by Technology
1.4.3 Europe Molecular Diagnostics Market, by Application
1.4.4 Europe Molecular Diagnostics Market, by End User
1.4.5 Europe Molecular Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Executive Summary
Chapter 3. Market Overview
3.1 Introduction
3.2 Drivers, Restraints and Opportunities
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Europe Molecular Diagnostics Market
4.1 Europe Molecular Diagnostics Market by Product & Services
4.1.1 Europe Molecular Diagnostics Reagents & Kits Market by Country
4.1.2 Europe Molecular Diagnostics Instruments Market by Country
4.1.3 Europe Molecular Diagnostics Software & Services Market by Country
Chapter 5. Europe Molecular Diagnostics Market by Technology
5.1 Introduction
5.1.1 Europe Polymerase Chain Reaction Molecular Diagnostics Market by Country
5.1.2 Europe Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country
5.1.3 Europe Hybridization Molecular Diagnostics Market by Country
5.1.4 Europe DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country
5.1.5 Europe Microarray Molecular Diagnostics Market by Country
5.1.6 Europe Other Technologies Market by Country
Chapter 6. Europe Molecular Diagnostics Market by Application
6.1 Introduction
6.1.1 Europe Infectious Diseases Molecular Diagnostics Market by Country
6.1.2 Europe Infectious Diseases Molecular Diagnostics Market by Type
6.1.2.1 Europe Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country
6.1.2.2 Europe Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country
6.1.2.3 Europe Human Papillomavirus Molecular Diagnostics Market by Country
6.1.2.4 Europe Human Immunodeficiency Virus Molecular Diagnostics Market by Country
6.1.2.5 Europe Tuberculosis Molecular Diagnostics Market by Country
6.1.2.6 Europe Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country
6.1.2.7 Europe Molecular Diagnostics in Other Infectious Diseases Market by Country
6.1.3 Europe Oncology Molecular Diagnostics Market by Country
6.1.4 Europe Oncology Molecular Diagnostics Market by Type
6.1.4.1 Europe Breast Cancer Molecular Diagnostics Market by Country
6.1.4.2 Europe Colorectal Cancer Molecular Diagnostics Market by Country
6.1.4.3 Europe Prostate Cancer Molecular Diagnostics Market by Country
6.1.4.4 Europe Other Cancers Molecular Diagnostics Market by Country
6.1.5 Europe Blood Screening Molecular Diagnostics Market by Country
6.1.6 Europe Genetic Tests Molecular Diagnostics Market by Country
6.1.7 Europe Microbiology Molecular Diagnostics Market by Country
6.1.8 Europe Other Applications Market by Country
Chapter 7. Europe Molecular Diagnostics Market by End User
7.1 Introduction
7.1.1 Europe Molecular Diagnostics Market for Hospital & Academic Laboratories by Country
7.1.2 Europe Molecular Diagnostics Market for Reference Laboratories by Country
7.1.3 Europe Molecular Diagnostics Market for Other End Users by Country
Chapter 8. Europe Molecular Diagnostics Market by Country
8.1 Introduction
8.2 Germany Molecular Diagnostics Market
8.2.1 Germany Molecular Diagnostics Market by Product & Services
8.2.2 Germany Molecular Diagnostics Market by Technology
8.2.3 Germany Molecular Diagnostics Market by Application
8.2.3.1 Germany Infectious Diseases Molecular Diagnostics Market by Type
8.2.3.2 Germany Oncology Molecular Diagnostics Market by Type
8.2.4 Germany Molecular Diagnostics Market by End User
8.3 UK Molecular Diagnostics Market
8.3.1 UK Molecular Diagnostics Market by Product & Services
8.3.2 UK Molecular Diagnostics Market by Technology
8.3.3 UK Molecular Diagnostics Market by Application
8.3.3.1 UK Infectious Diseases Molecular Diagnostics Market by Type
8.3.3.2 UK Oncology Molecular Diagnostics Market by Type
8.3.4 UK Molecular Diagnostics Market by End User
8.4 France Molecular Diagnostics Market
8.4.1 France Molecular Diagnostics Market by Product & Services
8.4.2 France Molecular Diagnostics Market by Technology
8.4.3 France Molecular Diagnostics Market by Application
8.4.3.1 France Infectious Diseases Molecular Diagnostics Market by Type
8.4.3.2 France Oncology Molecular Diagnostics Market by Type
8.4.4 France Molecular Diagnostics Market by End User
8.5 Russia Molecular Diagnostics Market
8.5.1 Russia Molecular Diagnostics Market by Product & Services
8.5.2 Russia Molecular Diagnostics Market by Technology
8.5.3 Russia Molecular Diagnostics Market by Application
8.5.3.1 Russia Infectious Diseases Molecular Diagnostics Market by Type
8.5.3.2 Russia Oncology Molecular Diagnostics Market by Type
8.5.4 Russia Molecular Diagnostics Market by End User
8.6 Spain Molecular Diagnostics Market
8.6.1 Spain Molecular Diagnostics Market by Product & Services
8.6.2 Spain Molecular Diagnostics Market by Technology
8.6.3 Spain Molecular Diagnostics Market by Application
8.6.3.1 Spain Infectious Diseases Molecular Diagnostics Market by Type
8.6.3.2 Spain Oncology Molecular Diagnostics Market by Type
8.6.4 Spain Molecular Diagnostics Market by End User
8.7 Italy Molecular Diagnostics Market
8.7.1 Italy Molecular Diagnostics Market by Product & Services
8.7.2 Italy Molecular Diagnostics Market by Technology
8.7.3 Italy Molecular Diagnostics Market by Application
8.7.3.1 Italy Infectious Diseases Molecular Diagnostics Market by Type
8.7.3.2 Italy Oncology Molecular Diagnostics Market by Type
8.7.4 Italy Molecular Diagnostics Market by End User
8.8 Rest of Europe Molecular Diagnostics Market
8.8.1 Rest of Europe Molecular Diagnostics Market by Product & Services
8.8.2 Rest of Europe Molecular Diagnostics Market by Technology
8.8.3 Rest of Europe Molecular Diagnostics Market by Application
8.8.3.1 Rest of Europe Infectious Diseases Molecular Diagnostics Market by Type
8.8.3.2 Rest of Europe Oncology Molecular Diagnostics Market by Type
8.8.4 Rest of Europe Molecular Diagnostics Market by End User
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.2 Qiagen N.V.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Roche Diagnostics
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Grifols
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.5 Siemens Healthcare (Siemens AG)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Becton Dickinson and Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense